Setting the Top 10 Research Priorities for Psychedelic-Assisted Cancer Therapy in Canada
Summary
This project aims to find out which research questions about psychedelic-assisted cancer therapy (e.g., magic mushrooms) are most important for helping people with cancer. Psychedelic-assisted cancer therapy (PACT) may help reduce strong feelings of anxiety, depression, and hopelessness in people with cancer. Early research shows it could be an effective treatment, but this has not been fully tested yet. To help guide future research on PACT, we plan to conduct a priority-setting partnership project to identify the most important unanswered questions about PACT from patients, family caregivers, healthcare providers, and policymakers.
Eligibility
Eligible ages: 18 to 110
Accepts healthy participants: Yes
Inclusion criteria:
All participants should be:
a) Aged 18 or older
b) Living in Canada
c) Able to read, write, and speak in English or French
d) Abe to access to an electronic device (i.e., computer, tablet, smart phone) with internet connection
People living with cancer should be:
- Diagnosed with or having been diagnosed with any type of cancer (current or in remission)
People who are cancer caregivers should be:
- A person who provides support, whether practical, mental, emotional, physical, spiritual, etc., for someone living with cancer, but does not receive payment for their caregiving
People who are healthcare workers should be
- Doctors, nurses, therapists, social workers, and other health professionals involved in cancer care, mental health, palliative care, psychedelic-assisted treatments or related areas.
People who are policymakers should be:
- Involved in health policy, government, regulation, or making decisions about healthcare.
Participate
Fill out the following form if you want to participate in this research
Collection of personal information
Your personal information is collected under
the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If
you have any questions about the collection or use of this information, please visit our
Access to Information page.
Additional information
Contact information
Participants can access the survey at: https://survey.ucalgary.ca/jfe/form/SV_czITXUHWzlAsUtM If participants require accomodations to fill out the survey, please contact Nisha Marshall (graduate student) at nisha.marshall@ucalgary.ca.
Principal investigator:
Linda Ellen Carlson
Clinical trial:
No
REB-ID:
HREBA.CC-25-0427
External links